Today: 4 April 2026
Browse Category

Stock Market 3 October 2025 - 4 October 2025

IonQ’s 2025 Quantum Leap: Surging Stock, Bold Ambitions & How It Compares to Rigetti and D-Wave

IonQ’s 2025 Quantum Leap: Surging Stock, Bold Ambitions & How It Compares to Rigetti and D-Wave

IonQ shares soared over 700% year-over-year in 2025, reaching an all-time high near $75 and a market cap of about $20–22 billion. Q2 revenue jumped 82% to $20.7 million, but the company posted a $177.5 million net loss. IonQ acquired Oxford Ionics for $1.08 billion and announced technical breakthroughs in quantum networking and drug discovery. Amazon disclosed a $36.7 million stake.
Bitcoin Miner to AI Cloud Sensation: Why Iris Energy (IREN) Stock Is Soaring in 2025

Iris Energy’s Dual Engine Revolution: Can This Bitcoin Miner Outshine Rivals in 2025 and Beyond?

Iris Energy reported FY-2025 revenue of US$501.0 million, up 168% from the prior year, as bitcoin mining and AI cloud revenues climbed. The company mined 5,499 BTC, with average bitcoin prices more than doubling to US$88,100. Net income reached US$86.9 million, reversing last year’s loss. Electricity costs averaged 3.8c/kWh, supporting gross margins near 75%.
CIFR Stock Soars: Could Cipher Mining Be the Next Bitcoin Powerhouse?

CIFR Stock Soars: Could Cipher Mining Be the Next Bitcoin Powerhouse?

Cipher Mining (CIFR) reported Q2 2025 revenue of $44 million and adjusted earnings of $30 million, with self-mining capacity at 16.8 EH/s. The company signed a 10-year AI-hosting deal with Fluidstack/Google, financing the pivot with a $1.1 billion convertible note. Analysts raised price targets to $15–17. CIFR shares rose 137.5% year-to-date by late September.
Rocket Lab Stock Skyrockets 700% – Is RKLB Ready for Its Next Giant Leap?

Rocket Lab Stock on a Mission in 2025: Is RKLB the Next Space Launch Leader?

Rocket Lab posted record Q2 2025 revenue of $144 million, up 36% year-over-year, with gross margins rising 650 basis points. The company acquired Geost for $275 million and Mynaric for $75 million, expanding into missile-warning and laser communications. Backlog neared $1 billion, with major contracts from NASA, Synspective, and the U.S. Department of Defense. Management reorganized under a holding company structure.
Diginex (DGNX) – The ESG Tech Stock Soaring in 2025: What Investors Need to Know

Diginex (DGNX) – The ESG Tech Stock Soaring in 2025: What Investors Need to Know

Diginex shares surged over 3,000% in 2025, closing near $16.50 after trading below $1 earlier in the year. The company’s market cap reached $3 billion despite 2025 revenues of just $2.04 million and a net loss of $5.21 million. Diginex provides ESG compliance software and went public in January 2025. The stock trades at over 1,400 times sales, reflecting investor bets on rapid growth.
Mercurity Fintech (MFH) Stock Explodes Amid Crypto & AI Bets – 1,000% Rally or Bubble?

Up 1,400% in a Year: Is Mercurity Fintech (MFH) the Next Crypto-Fintech Breakout or a Bubble?

Mercurity Fintech Holding (NASDAQ: MFH) stock has soared over 1,400% in the past year, reaching an all-time high near $30. The company pivoted to a $500 million crypto treasury strategy focused on Solana, securing a $200 million credit line from Solana Ventures after shelving a planned $43.7 million offering. MFH joined the Russell 2000 and S&P Global BMI in 2025. Despite this, 2024 revenue was just $1.01 million, with a $4.5 million net loss.
Ondas Holdings Skyrockets into the U.S. Defense Drone Race – Is ONDS the Next Tech Titan?

Ondas Holdings: Is This Drone‑Defense Upstart the Next Big Thing or a Bubble About to Burst?

Ondas Holdings (NASDAQ: ONDS) closed at $9.91 on Oct. 3, 2025, up 1,190% over the past year, with a market cap of $3.24 billion despite trailing-12-month revenue of $16.13 million. Wall Street’s 12-month price target is $5.67. Recent news includes a 500-unit drone order, record Q2 revenue, and its wireless protocol being chosen by the Association of American Railroads. The company employs about 124 people in Massachusetts.
Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Cidara Therapeutics (NASDAQ: CDTX) 2025 Investment Analysis – Will This Anti‑Flu Innovator Keep Soaring?

Cidara Therapeutics’ stock rose 279% year-to-date, closing at $101.99 on Oct. 3, 2025, up from $26.88 at the start of the year. The company’s CD388 drug showed 76% protection against flu in a Phase 2b trial. BARDA awarded up to $339 million in October for manufacturing and clinical development. As of June, Cidara held $516.9 million in cash.
Super Micro Computer (SUPX) 2025: Can the AI‑Server Pure‑Play Keep Its Edge?

Super Micro Computer (SUPX) 2025: Can the AI‑Server Pure‑Play Keep Its Edge?

Super Micro Computer reported fiscal 2025 net sales of $22 billion, up sharply from two years ago, but fourth-quarter revenue of $5.8 billion missed estimates and net income fell to $195 million. Management lowered fiscal 2026 sales guidance to at least $33 billion, down from $40 billion. Shares dropped 15.5% after the Q4 miss and guidance cut. Analysts remain cautious amid margin pressure and volatile stock performance.
Quantum Computing Inc. (QUBT): 2025’s Wild 3,200% Quantum Stock Surge – Boom or Bubble?

Quantum Computing Inc. (QUBT): 2025’s Wild 3,200% Quantum Stock Surge – Boom or Bubble?

QUBT shares surged over 3,200% in 12 months, trading near $24–25 in Q4 2025 after a low of $0.65. The company raised $500 million in September, bringing cash reserves to $850 million despite trailing 12-month revenue under $0.3 million and a $68.5 million net loss in 2024. Shares saw sharp swings in 2025, plunging early before rebounding in Q2 amid renewed quantum tech interest.
Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Rigetti shares surged over 4,000% in 12 months, trading at $40.06 intraday after record highs driven by new contracts and system orders. Q2 revenue fell 41% to $1.8 million, with a net loss of $39.7 million. The company raised $350 million, holding $571.6 million in cash and no debt. Recent wins include $5.7 million in system orders and a $5.8 million government contract.
Regencell (RGC) Stock Skyrockets 64,000% – Miracle Biotech or Bubble?

Regencell (RGC) Stock Skyrockets 64,000% – Miracle Biotech or Bubble?

Regencell Bioscience (RGC) stock soared over 82,000% in 2025, peaking at $83.60 before plunging 74% after a 38-for-1 stock split and speculative trading frenzy. The Hong Kong biotech, which has no revenue and focuses on Traditional Chinese Medicine for neurocognitive disorders, now trades near $17 with an $8.5 billion market cap. Regulators halted trading multiple times amid extreme volatility.
4 October 2025
Huawei Mate X5 Ultimate 5G Shakes Up the Foldable Phone Wars

Huawei Mate X5 Ultimate 5G Shakes Up the Foldable Phone Wars

Huawei launched the Mate X5 Ultimate 5G foldable phone in China in September 2023, featuring a 7.85-inch inner OLED and 6.4-inch cover display, both at 120Hz. Powered by the Kirin 9000S 5G chip, it offers up to 16GB RAM and 1TB storage, a triple rear camera, and a 5,060 mAh battery. The device sold out quickly, boosting Huawei’s share of the global foldable market to as high as 37%.
Tarsus Eyedrop Breakthrough Sends Stock Soaring: 10.9% Rally and Counting

Tarsus Eyedrop Breakthrough Sends Stock Soaring: 10.9% Rally and Counting

Tarsus (NASDAQ:TARS) surged 10.9% to $65.17 on Oct. 3, 2025, after reporting Q2 net product revenue of $102.7 million, up 152% year-over-year, driven by XDEMVY eyedrop sales. Shares have climbed 31% in the past month and 84% over the year. Wall Street consensus rates the stock a “Buy,” with average 12-month targets near $71. Losses are narrowing as sales rise and cash reserves remain strong.
Humana (HUM) Stock Skyrockets on Medicare News – What Investors Must Know Today

Humana Stock Skyrockets as Medicare Advantage News Ignites Rally

Humana shares closed at $283.72 on Oct. 3, 2025, up 10.6% after stronger-than-expected Medicare Advantage metrics and improved 2026 plan benefits. The company reaffirmed 2025 EPS guidance and raised its revenue outlook to at least $128 billion. Humana will reduce its Medicare Advantage footprint to 85% of U.S. counties next year. Trading volume spiked as investors reacted to the news.
3 October 2025
White Mountains Stock Skyrockets on $1.75B Bamboo Deal and Major CEO Shake-Up

White Mountains Stock Rockets +10% on $1.75B Bamboo Deal – What Investors Need to Know

White Mountains shares surged 10.6% to $1,841.34 on Oct. 3, 2025, after announcing a $1.75 billion sale of a 77% stake in Bamboo Ide8 to CVC Capital Partners. The deal will bring WTM about $840 million in cash and boost book value per share by $310. WTM will retain roughly 15% of Bamboo. The move contrasts with a recent 2.7% drop in the S&P Insurance Index.
QuantumScape (QS) Stock Skyrockets 14% on Solid-State EV Battery Breakthrough – Can the Rally Continue?

QuantumScape Rockets 11% to $15.92 on Solid-State Battery Breakthroughs

QuantumScape closed at $15.92 on Oct. 3, up 11.33%, nearing its 52-week high after a 150% rally this year. The company announced a partnership with Corning on Sept. 30 to scale ceramic separator manufacturing for solid-state batteries. In September, QuantumScape and VW’s PowerCo demonstrated their QSE-5 cells in a Ducati electric race bike at IAA Mobility. Q2 results showed an EPS loss of $0.20 and $798 million in cash.
Rigetti Computing’s Quantum Leap: Stock Soars on Breakthroughs and Bold Bets

Rigetti (RGTI) Quantum Stock Rockets on Big Deals – Is the $10B Hype Real?

Rigetti shares traded near record highs at $35–39 on Oct. 3, 2025, pushing its market cap to $11.5 billion, up about 2,500% over 12 months. The rally follows new quantum computing orders and a $5.8 million U.S. Air Force deal. Despite just $1.8 million in Q2 revenue and a $39.7 million net loss, Rigetti raised $385 million in equity and held $571.6 million cash with no debt. Analyst price targets lag current levels.
Quantum Leap: D-Wave (QBTS) Stock Skyrockets 2000% Amid Fed Rate Cuts and AI-Fueled Quantum Breakthroughs

Quantum Computing Frenzy: D-Wave (QBTS) Stock Surges 289% in 2025 on Breakthrough Deals

QBTS closed at a record $32.5 on Oct. 3, up 289% year-to-date, after D-Wave announced $5.7M in new orders and reported strong pilot results with UK police. Volume surged to 77 million shares as technical indicators flashed overbought. Q2 revenue rose 42% to $3.1M, with a $819M cash balance after a $400M equity raise. Analysts forecast $24.8M in 2025 revenue; most rate the stock a Buy.

Stock Market Today

  • ASX Stocks: Buybacks Signal Confidence Amid Market Volatility
    April 4, 2026, 12:09 PM EDT. ASX companies deploy share buybacks as strategic tools during volatile market conditions. These repurchase programmes reflect management confidence and financial strength, often initiated when share prices dip below intrinsic values. Northern Star Resources recently launched a A$500 million buyback following a sharp stock decline despite solid production metrics. The timing of buybacks amid selloffs signals management's belief in valuation dislocations rather than fundamental business weaknesses. Effective buyback execution involves careful coordination with earnings releases and liquidity management, illustrating the complex strategic decisions underpinning capital returns in Australian equities.
Go toTop